Your browser doesn't support javascript.
loading
Hypoxia and Hypoxia-Inducible Factors in Lymphedema.
Jiang, Xinguo; Tian, Wen; Kim, Dongeon; McQuiston, Alexander S; Vinh, Ryan; Rockson, Stanley G; Semenza, Gregg L; Nicolls, Mark R.
Afiliação
  • Jiang X; VA Palo Alto Health Care System, Palo Alto, CA, United States.
  • Tian W; Stanford University School of Medicine, Stanford, CA, United States.
  • Kim D; VA Palo Alto Health Care System, Palo Alto, CA, United States.
  • McQuiston AS; Stanford University School of Medicine, Stanford, CA, United States.
  • Vinh R; VA Palo Alto Health Care System, Palo Alto, CA, United States.
  • Rockson SG; Stanford University School of Medicine, Stanford, CA, United States.
  • Semenza GL; VA Palo Alto Health Care System, Palo Alto, CA, United States.
  • Nicolls MR; Stanford University School of Medicine, Stanford, CA, United States.
Front Pharmacol ; 13: 851057, 2022.
Article em En | MEDLINE | ID: mdl-35450048
ABSTRACT
Lymphedema is a chronic inflammatory disorder characterized by edema, fat deposition, and fibrotic tissue remodeling. Despite significant advances in lymphatic biology research, our knowledge of lymphedema pathology is incomplete. Currently, there is no approved pharmacological therapy for this debilitating disease. Hypoxia is a recognized feature of inflammation, obesity, and fibrosis. Understanding hypoxia-regulated pathways in lymphedema may provide new insights into the pathobiology of this chronic disorder and help develop new medicinal treatments.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2022 Tipo de documento: Article